Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081131

Director acquired 4,374 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
JEFFS ROGER Director 2015-11-24 Conversion +4,374 $5.94 $25,982 4,374 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
JEFFS ROGER Director 2015-11-24 Grant or award · 8% Convertible Note +4,374 0 D: show line 2 in the form
Loading xslF345X03/a4.xml…